Sotatercept, an activin-signaling inhibitor, reduces morbidity and mortality among patients with long-standing pulmonary ...
Prescribing the biologic drug sotatercept alongside standard treatment for the most severe form of pulmonary hypertension ...
For recently diagnosed pulmonary arterial hypertension (PAH), adding sotatercept (Winrevair) to standard care lowered the ...
About Kaia Health Kaia Health is a global leader in digital therapeutics, providing evidence-based programs for chronic disease management. Its clinically validated Kaia Breathe solution brings ...
Pulmonary arterial hypertension (PAH) continues to be a condition associated with a high morbidity and mortality despite the advances in treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback